Rifaximin 3 Times/Day (TID) for Non-Constipation Irritable Bowel Syndrome (IBS)

Completed · Phase 3 · Has a placebo group

Conditions studied: Non-Constipation Irritable Bowel Syndrome

In brief

To evaluate the efficacy of a 14-day course of rifaximin given 3 times a day vs. placebo in providing adequate relief of IBS symptoms.

Key facts

Study ID

NCT00731679

Run by

Bausch Health Americas, Inc.

People needed

623

Starts

2008-07-01

Expected to finish

2009-09-01

Last updated by the study team

2019-11-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Confirmed IBS diagnosis per Rome II for diagnosis of IBS.
• Colonoscopy within 2 years as part of IBS diagnostic evaluation.
• Has active symptoms of non-constipation IBS at baseline as measured by average daily scores for abdominal pain/discomfort, bloating, and stool consistency.

You may not qualify if…

• Symptoms of constipation.
• History of other gastrointestinal diseases.
• Type 1 or 2 diabetes.
• Lactose intolerance not controlled by lactose-free diet.

Where it is running

• Study site — Phoenix, Arizona, United States
• Study site — Sierra Vista, Arizona, United States
• Study site — Tucson, Arizona, United States
• Study site — Little Rock, Arkansas, United States
• Study site — Little Rock, Arkansas, United States
• Study site — Sherwood, Arkansas, United States
• Study site — Anaheim, California, United States
• Study site — Lancaster, California, United States
• Study site — Los Angeles, California, United States
• Study site — Murrieta, California, United States
• Study site — San Diego, California, United States
• Study site — Lakewood, Colorado, United States
• Study site — Bridgeport, Connecticut, United States
• Study site — Torrington, Connecticut, United States
• Study site — Altamonte Springs, Florida, United States
• Study site — Boynton Beach, Florida, United States
• Study site — Gainesville, Florida, United States
• Study site — Hollywood, Florida, United States
• Study site — Jupiter, Florida, United States
• Study site — Lauderdale Lakes, Florida, United States
• Study site — Maitland, Florida, United States
• Study site — Naples, Florida, United States
• Study site — New Port Richey, Florida, United States
• Study site — Orlando, Florida, United States
• Study site — Hueytown, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.